{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:17:09Z","timestamp":1788279429244,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41593-026-02363-4","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:01:45Z","timestamp":1787130105000},"page":"2164-2175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cortical thickness changes precede high levels of amyloid by at least 7 years"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8008-902X","authenticated-orcid":false,"given":"James M.","family":"Roe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4458-113X","authenticated-orcid":false,"given":"William J.","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kon","family":"Grydeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7563-250X","authenticated-orcid":false,"given":"Maksim","family":"Slivka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Luis","family":"Alatorre-Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6005-7178","authenticated-orcid":false,"given":"Pablo F.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0724-3542","authenticated-orcid":false,"given":"\u00d8ystein","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edvard O. S.","family":"Gr\u00f8dem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esten H.","family":"Leonardsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaQie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9984-9797","authenticated-orcid":false,"given":"Tormod","family":"Fladby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atle","family":"Bj\u00f8rnerud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-1123","authenticated-orcid":false,"given":"Kristine B.","family":"Walhovd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2502-8774","authenticated-orcid":false,"given":"Anders M.","family":"Fjell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-9156","authenticated-orcid":false,"given":"Didac","family":"Vidal-Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-1090","authenticated-orcid":false,"given":"Yunpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2363_CR1","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"2363_CR2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"2363_CR3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 280\u2013292 (2011).","journal-title":"Alzheimers Dement."},{"key":"2363_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack, C. R. et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 9, 119\u2013128 (2010).","journal-title":"Lancet Neurol."},{"key":"2363_CR5","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia, J. et al. Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N. Engl. J. Med. 390, 712\u2013722 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2363_CR6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N. Engl. J. Med. 367, 795\u2013804 (2012).","journal-title":"N. Engl. J. Med."},{"key":"2363_CR7","doi-asserted-by":"crossref","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","volume":"91","author":"E McDade","year":"2018","unstructured":"McDade, E. et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology 91, e1295\u2013e1306 (2018).","journal-title":"Neurology"},{"key":"2363_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41583-023-00779-6","volume":"25","author":"AL Young","year":"2024","unstructured":"Young, A. L. et al. Data-driven modelling of neurodegenerative disease progression: thinking outside the black box. Nat. Rev. Neurosci. 25, 111\u2013130 (2024).","journal-title":"Nat. Rev. Neurosci."},{"key":"2363_CR9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/brain\/awy050","volume":"141","author":"NP Oxtoby","year":"2018","unstructured":"Oxtoby, N. P. et al. Data-driven models of dominantly-inherited Alzheimer\u2019s disease progression. Brain 141, 1529\u20131544 (2018).","journal-title":"Brain"},{"key":"2363_CR10","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/brain\/awu176","volume":"137","author":"AL Young","year":"2014","unstructured":"Young, A. L. et al. A data-driven model of biomarker changes in sporadic Alzheimer\u2019s disease. Brain 137, 2564\u20132577 (2014).","journal-title":"Brain"},{"key":"2363_CR11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuroimage.2018.11.024","volume":"186","author":"V Venkatraghavan","year":"2019","unstructured":"Venkatraghavan, V., Bron, E. E., Niessen, W. J. & Klein, S. Disease progression timeline estimation for Alzheimer\u2019s disease using discriminative event based modeling. Neuroimage 186, 518\u2013532 (2019).","journal-title":"Neuroimage"},{"key":"2363_CR12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/alz.12249","volume":"17","author":"TM Harrison","year":"2021","unstructured":"Harrison, T. M., Du, R., Klencklen, G., Baker, S. L. & Jagust, W. J. Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults. Alzheimers Dement. 17, 1085\u20131096 (2021).","journal-title":"Alzheimers Dement."},{"key":"2363_CR13","doi-asserted-by":"crossref","first-page":"103409","DOI":"10.1016\/j.nicl.2023.103409","volume":"38","author":"S Hani Hojjati","year":"2023","unstructured":"Hani Hojjati, S. et al. Distinct and joint effects of low and high levels of A\u03b2 and tau deposition on cortical thickness. Neuroimage Clin. 38, 103409 (2023).","journal-title":"Neuroimage Clin."},{"key":"2363_CR14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jalz.2016.08.010","volume":"13","author":"J Pegueroles","year":"2017","unstructured":"Pegueroles, J. et al. Longitudinal brain structural changes in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 13, 499\u2013509 (2017).","journal-title":"Alzheimers Dement."},{"key":"2363_CR15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jalz.2017.09.013","volume":"14","author":"V Montal","year":"2018","unstructured":"Montal, V. et al. Cortical microstructural changes along the Alzheimer\u2019s disease continuum. Alzheimers Dement. 14, 340\u2013351 (2018).","journal-title":"Alzheimers Dement."},{"key":"2363_CR16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24186","volume":"76","author":"J Fortea","year":"2014","unstructured":"Fortea, J. et al. Cerebrospinal fluid \u03b2-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. Ann. Neurol. 76, 223\u2013230 (2014).","journal-title":"Ann. Neurol."},{"key":"2363_CR17","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/brain\/awq187","volume":"133","author":"G Ch\u00e9telat","year":"2010","unstructured":"Ch\u00e9telat, G. et al. Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain 133, 3349\u20133358 (2010).","journal-title":"Brain"},{"key":"2363_CR18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2013.09.028","volume":"35","author":"SC Johnson","year":"2014","unstructured":"Johnson, S. C. et al. Amyloid burden and neural function in people at risk for Alzheimer\u2019s Disease. Neurobiol. Aging 35, 576\u2013584 (2014).","journal-title":"Neurobiol. Aging"},{"key":"2363_CR19","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac134","volume":"4","author":"G Salvad\u00f3","year":"2022","unstructured":"Salvad\u00f3, G. et al. Brain alterations in the early Alzheimer\u2019s continuum with amyloid-\u03b2, tau, glial and neurodegeneration CSF markers. Brain Commun. 4, fcac134 (2022).","journal-title":"Brain Commun."},{"key":"2363_CR20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2013.02.005","volume":"54","author":"M Grand\u2019Maison","year":"2013","unstructured":"Grand\u2019Maison, M. et al. Early cortical thickness changes predict \u03b2-amyloid deposition in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 54, 59\u201367 (2013).","journal-title":"Neurobiol. Dis."},{"key":"2363_CR21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S1474-4422(24)00335-1","volume":"23","author":"CRS Belder","year":"2024","unstructured":"Belder, C. R. S. et al. Brain volume change following anti-amyloid \u03b2 immunotherapy for Alzheimer\u2019s disease: amyloid-removal-related pseudo-atrophy. Lancet Neurol. 23, 1025\u20131034 (2024).","journal-title":"Lancet Neurol."},{"key":"2363_CR22","volume":"220","author":"JC Beer","year":"2020","unstructured":"Beer, J. C. et al. Longitudinal ComBat: a method for harmonizing longitudinal multi-scanner imaging data. Neuroimage 220, 117129 (2020).","journal-title":"Neuroimage"},{"key":"2363_CR23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuroimage.2018.05.070","volume":"178","author":"AF Alexander-Bloch","year":"2018","unstructured":"Alexander-Bloch, A. F. et al. On testing for spatial correspondence between maps of human brain structure and function. Neuroimage 178, 540\u2013551 (2018).","journal-title":"Neuroimage"},{"key":"2363_CR24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41562-020-0912-z","volume":"4","author":"U Simonsohn","year":"2020","unstructured":"Simonsohn, U., Simmons, J. P. & Nelson, L. D. Specification curve analysis. Nat. Hum. Behav. 4, 1208\u20131214 (2020).","journal-title":"Nat. Hum. Behav."},{"key":"2363_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk, W. E. et al. The Centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 11, 1\u201315 (2015).","journal-title":"Alzheimers Dement."},{"key":"2363_CR26","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1093\/brain\/awac213","volume":"145","author":"TJ Betthauser","year":"2022","unstructured":"Betthauser, T. J. et al. Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts. Brain 145, 4065\u20134079 (2022).","journal-title":"Brain"},{"key":"2363_CR27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne, V. L. et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 12, 357\u2013367 (2013).","journal-title":"Lancet Neurol."},{"key":"2363_CR28","doi-asserted-by":"crossref","first-page":"e2026","DOI":"10.1212\/WNL.0000000000009405","volume":"94","author":"E Vilaplana","year":"2020","unstructured":"Vilaplana, E. et al. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease. Neurology 94, e2026\u2013e2036 (2020).","journal-title":"Neurology"},{"key":"2363_CR29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/alz.12224","volume":"17","author":"V Montal","year":"2021","unstructured":"Montal, V. et al. Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer\u2019s disease. Alzheimers Dement. 17, 618\u2013628 (2021).","journal-title":"Alzheimers Dement."},{"key":"2363_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78471-3","volume":"10","author":"D Vidal-Pineiro","year":"2020","unstructured":"Vidal-Pineiro, D. et al. Cellular correlates of cortical thinning throughout the lifespan. Sci. Rep. 10, 1\u201314 (2020) .","journal-title":"Sci. Rep."},{"key":"2363_CR31","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/brain\/awae116","volume":"147","author":"KA Cody","year":"2024","unstructured":"Cody, K. A. et al. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer\u2019s disease. Brain 147, 2144\u20132157 (2024).","journal-title":"Brain"},{"key":"2363_CR32","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele, R. et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 28, 2381\u20132387 (2022).","journal-title":"Nat. Med."},{"key":"2363_CR33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/alz.12292","volume":"17","author":"S Ingala","year":"2021","unstructured":"Ingala, S. et al. Application of the ATN classification scheme in a population without dementia: findings from the EPAD cohort. Alzheimers Dement. 17, 1189\u20131204 (2021).","journal-title":"Alzheimers Dement."},{"key":"2363_CR34","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/brain\/awx120","volume":"140","author":"P Parbo","year":"2017","unstructured":"Parbo, P. et al. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer\u2019s disease. Brain 140, 2002\u20132011 (2017).","journal-title":"Brain"},{"key":"2363_CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.12.012","volume":"88","author":"L Batzu","year":"2020","unstructured":"Batzu, L., Westman, E. & Pereira, J. B. Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer\u2019s disease. Neurobiol. Aging 88, 61\u201370 (2020).","journal-title":"Neurobiol. Aging"},{"key":"2363_CR36","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","volume":"35","author":"CE Hanzel","year":"2014","unstructured":"Hanzel, C. E. et al. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer\u2019s disease. Neurobiol. Aging 35, 2249\u20132262 (2014).","journal-title":"Neurobiol. Aging"},{"key":"2363_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-62","volume":"9","author":"MT Ferretti","year":"2012","unstructured":"Ferretti, M. T., Allard, S., Partridge, V., Ducatenzeiler, A. & Cuello, A. C. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer\u2019s disease-like amyloid pathology. J. Neuroinflammation 9, 62 (2012).","journal-title":"J. Neuroinflammation"},{"key":"2363_CR38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuron.2013.01.002","volume":"77","author":"W Jagust","year":"2013","unstructured":"Jagust, W. Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron 77, 219\u2013234 (2013).","journal-title":"Neuron"},{"key":"2363_CR39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pneurobio.2014.02.004","volume":"117","author":"AM Fjell","year":"2014","unstructured":"Fjell, A. M., McEvoy, L., Holland, D., Dale, A. M. & Walhovd, K. B. What is normal in normal aging? Effects of aging, amyloid and Alzheimer\u2019s disease on the cerebral cortex and the hippocampus. Prog. Neurobiol. 117, 20\u201340 (2014).","journal-title":"Prog. Neurobiol."},{"key":"2363_CR40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1474-4422(23)00128-X","volume":"22","author":"WJ Jagust","year":"2023","unstructured":"Jagust, W. J., Teunissen, C. E. & DeCarli, C. The complex pathway between amyloid \u03b2 and cognition: implications for therapy. Lancet Neurol. 22, 847\u2013857 (2023).","journal-title":"Lancet Neurol."},{"key":"2363_CR41","unstructured":"Demidenko, E. Mixed Models: Theory and Applications with R (Wiley, 2013)."},{"key":"2363_CR42","doi-asserted-by":"crossref","unstructured":"Pinheiro, J. & Bates, D. Mixed-Effects Models in S and S-PLUS (Springer-Verlag, 2000).","DOI":"10.1007\/978-1-4419-0318-1"},{"key":"2363_CR43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fnins.2017.00281","volume":"11","author":"PS Insel","year":"2017","unstructured":"Insel, P. S. et al. Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition: evidence for emerging amyloid pathology in Alzheimer\u2019s disease. Front. Neurosci. 11, 281 (2017).","journal-title":"Front. Neurosci."},{"key":"2363_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","volume":"19","author":"W Jagust","year":"2018","unstructured":"Jagust, W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat. Rev. Neurosci. 19, 687\u2013700 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"2363_CR45","first-page":"1","volume":"12","author":"RL Joie","year":"2020","unstructured":"Joie, R. L. et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci. Transl. Med. 12, 1\u201313 (2020).","journal-title":"Sci. Transl. Med."},{"key":"2363_CR46","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1523\/JNEUROSCI.4409-12.2013","volume":"33","author":"M Wirth","year":"2013","unstructured":"Wirth, M. et al. Alzheimer\u2019s disease neurodegenerative biomarkers are associated with decreased cognitive function but not \u03b2-amyloid in cognitively normal older individuals. J. Neurosci. 33, 5553\u20135563 (2013).","journal-title":"J. Neurosci."},{"key":"2363_CR47","doi-asserted-by":"crossref","first-page":"e1347","DOI":"10.1212\/WNL.0000000000011524","volume":"96","author":"WJ Jagust","year":"2021","unstructured":"Jagust, W. J., Landau, S. M. & the Alzheimer\u2019s Disease Neuroimaging Initiative Temporal dynamics of \u03b2-amyloid accumulation in aging and Alzheimer disease. Neurology 96, e1347\u2013e1357 (2021).","journal-title":"Neurology"},{"key":"2363_CR48","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/brain\/aww015","volume":"139","author":"S Palmqvist","year":"2016","unstructured":"Palmqvist, S., Mattsson, N., Hansson, O. & the Alzheimer\u2019s Disease Neuroimaging Initiative Cerebrospinal fluid analysis detects cerebral amyloid-\u03b2 accumulation earlier than positron emission tomography. Brain 139, 1226\u20131236 (2016).","journal-title":"Brain"},{"key":"2363_CR49","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911170","volume":"11","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist, S. et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease. EMBO Mol. Med. 11, EMMM201911170 (2019).","journal-title":"EMBO Mol. Med."},{"key":"2363_CR50","doi-asserted-by":"publisher","unstructured":"Burnham, S. C. et al. When does Alzheimer\u2019s disease start? Robust estimates based on longitudinal A\u03b2-amyloid-PET in three large international cohorts. Preprint at SSRN https:\/\/doi.org\/10.2139\/ssrn.4757682 (2024).","DOI":"10.2139\/ssrn.4757682"},{"key":"2363_CR51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","volume":"79","author":"WJ Jansen","year":"2022","unstructured":"Jansen, W. J. et al. Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum. JAMA Neurol. 79, 228\u2013243 (2022).","journal-title":"JAMA Neurol."},{"key":"2363_CR52","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","volume":"16","author":"CR Jack","year":"2017","unstructured":"Jack, C. R. et al. Age-specific and sex-specific prevalence of cerebral \u03b2-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study. Lancet Neurol. 16, 435\u2013444 (2017).","journal-title":"Lancet Neurol."},{"key":"2363_CR53","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(25)00350-3","volume":"24","author":"CR Jack","year":"2025","unstructured":"Jack, C. R. et al. Lifetime and 10-year absolute risk of cognitive impairment in relation to amyloid PET severity: a retrospective, longitudinal cohort study. Lancet Neurol. 24, 1016\u20131025 (2025).","journal-title":"Lancet Neurol."},{"key":"2363_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","volume":"12","author":"CR Jack","year":"2016","unstructured":"Jack, C. R. et al. Suspected non-Alzheimer disease pathophysiology \u2014 concept and controversy. Nat. Rev. Neurol. 12, 117\u2013124 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"2363_CR55","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","volume":"30","author":"CR Jack","year":"2024","unstructured":"Jack, C. R. et al. Revised criteria for the diagnosis and staging of Alzheimer\u2019s disease. Nat. Med. 30, 2121\u20132124 (2024).","journal-title":"Nat. Med."},{"key":"2363_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53548-z","volume":"15","author":"JM Roe","year":"2024","unstructured":"Roe, J. M. et al. Brain change trajectories in healthy adults correlate with Alzheimer\u2019s related genetic variation and memory decline across life. Nat. Commun. 15, 10651 (2024).","journal-title":"Nat. Commun."},{"key":"2363_CR57","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1523\/JNEUROSCI.0391-14.2014","volume":"34","author":"AB Storsve","year":"2014","unstructured":"Storsve, A. B. et al. Differential longitudinal changes in cortical thickness, surface area and volume across the adult life span: regions of accelerating and decelerating change. J. Neurosci. 34, 8488\u20138498 (2014).","journal-title":"J. Neurosci."},{"key":"2363_CR58","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jalz.2011.09.172","volume":"8","author":"MW Weiner","year":"2012","unstructured":"Weiner, M. W. et al. The Alzheimer\u2019s disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement. 8, e111\u2013e194 (2012).","journal-title":"Alzheimers Dement."},{"key":"2363_CR59","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuroimage.2010.07.020","volume":"53","author":"M Reuter","year":"2010","unstructured":"Reuter, M., Rosas, H. D. & Fischl, B. Highly accurate inverse consistent registration: a robust approach. Neuroimage 53, 1181\u20131196 (2010).","journal-title":"Neuroimage"},{"key":"2363_CR60","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4","volume":"8","author":"B Fischl","year":"1999","unstructured":"Fischl, B., Sereno, M. I., Tootell, R. B. & Dale, A. M. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp. 8, 272\u2013284 (1999).","journal-title":"Hum. Brain Mapp."},{"key":"2363_CR61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/nimg.1998.0396","volume":"9","author":"B Fischl","year":"1999","unstructured":"Fischl, B., Sereno, M. I. & Dale, A. M. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9, 195\u2013207 (1999).","journal-title":"Neuroimage"},{"key":"2363_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-28795-7","volume":"13","author":"J Giorgio","year":"2022","unstructured":"Giorgio, J. et al. A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation. Nat. Commun. 13, 1\u201314 (2022).","journal-title":"Nat. Commun."},{"key":"2363_CR63","doi-asserted-by":"crossref","first-page":"103765","DOI":"10.1016\/j.nicl.2025.103765","volume":"46","author":"L Iaccarino","year":"2025","unstructured":"Iaccarino, L. et al. A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research. Neuroimage Clin. 46, 103765 (2025).","journal-title":"Neuroimage Clin."},{"key":"2363_CR64","first-page":"1","volume":"42","author":"D Ho","year":"2011","unstructured":"Ho, D., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Softw. 42, 1\u201328 (2011).","journal-title":"J. Stat. Softw."},{"key":"2363_CR65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroimage.2006.02.051","volume":"32","author":"X Han","year":"2006","unstructured":"Han, X. et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 32, 180\u2013194 (2006).","journal-title":"Neuroimage"},{"key":"2363_CR66","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroimage.2017.11.024","volume":"167","author":"J-P Fortin","year":"2018","unstructured":"Fortin, J.-P. et al. Harmonization of cortical thickness measurements across scanners and sites. Neuroimage 167, 104\u2013120 (2018).","journal-title":"Neuroimage"},{"key":"2363_CR67","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","volume":"82","author":"EC Mormino","year":"2014","unstructured":"Mormino, E. C. et al. Amyloid and APOE \u03b54 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82, 1760\u20131767 (2014).","journal-title":"Neurology"},{"key":"2363_CR68","doi-asserted-by":"crossref","unstructured":"Roe, J. M. Cortical thickness changes precede high levels of amyloid by at least seven years. GitHub https:\/\/github.com\/jamesmroe\/yearsBeforeAB (2026).","DOI":"10.1101\/2025.08.14.670398"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02363-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02363-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02363-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:25:54Z","timestamp":1788276354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02363-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2363"],"URL":"https:\/\/doi.org\/10.1038\/s41593-026-02363-4","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.J.J. serves on data monitoring committees for Lilly, holds equity in Optoceutics and Molecular Medicine, and receives research support from Biogen and grants from ZonMW, Alzheimer Nederland and St. Rinsum-Ponsen. E.H.L. is the CSO and a shareholder in baba.vision. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}